Mikael Dolsten - 25 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Issuer symbol
PFE
Transactions as of
25 Feb 2023
Transactions value $
-$1,548,007
Form type
4
Filing time
28 Feb 2023, 07:24:42 UTC
Previous filing
24 Feb 2023
Next filing
20 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Tax liability -$1.55M -37.1K -9.48% $41.75 354K 25 Feb 2023 Direct F1, F2
holding PFE Common Stock 1.88K 25 Feb 2023 By Rule 16b-3 Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2 Price is the closing price of Pfizer common stock on February 24, 2023.